Trace element supplementation in parenteral nutrition: Pharmacy, posology, and monitoring guidance

Nutrition

Volumn 25, Issue 11-12, 2009, Pages 1073-1084

  Hardy, Gil ^a   Menendez, Ana Maria ^b   Manzanares, William ^c  

^a MASSEY UNIVERSITY   (New Zealand)

^b Instituto Argentino de Educación e Investigación en Nutricion   (Argentina)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

Parenteral nutrition; Trace elements

Indexed keywords

CHROMIUM; COPPER; FLUORINE; IODINE; IRON; MANGANESE; MOLYBDENUM; SELENIUM; TRACE ELEMENT; ZINC;

BIOAVAILABILITY; CLINICAL FEATURE; DIET SUPPLEMENTATION; FOOD CONTAMINATION; HUMAN; LABORATORY TEST; PARENTERAL NUTRITION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SYMPTOM;

ADULT; BIOLOGICAL AVAILABILITY; CHILD; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; GUIDELINES AS TOPIC; HUMANS; NUTRITIONAL REQUIREMENTS; PARENTERAL NUTRITION; TRACE ELEMENTS;

EID: 70349976597     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.03.004     Document Type: Review

References (91)

1. National Institute for Health and Clinical Excellence. Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition; 2006 Available at: www.rcseng.ac.uk/publications/docs/nutrition_support_guidelines.html/vie w. Accessed December 2008.
2. Mertz W. Review of the scientific basis for establishing the essentiality of trace elements. Biol Trace Elem Res 66 (1998) 185-191
3. Standing Committee on the Scientific Evaluation of Dietary References Intakes, Food and Nutrition Board, and Institute of Medicine. Dietary references intakes (DRI) for calcium, phosphorus, magnesium, vitamin D and fluoride (1997), National Academy of Sciences, Washington, DC
4. Standing Committee on the Scientific Evaluation of Dietary References Intakes, Food and Nutrition Board, and Institute of Medicine. Dietary references intakes (DRI) for thiamin, riboflavin, vitamin B6, niacin, folate, vitamin B12 and choline (1998), National Academy of Sciences, Washington, DC
5. Standing Committee on the Scientific Evaluation of Dietary References Intakes, Food and Nutrition Board, Institute of Medicine. Antioxidants' role in chronic disease prevention still uncertain; huge doses considered risky (2000), National Academy of Sciences, Washington, DC
6. Standing Committee on the Scientific Evaluation of Dietary References Intakes, Food and Nutrition Board, and Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, molybdenum, nickel, silicon, vanadium and zinc (2001), National Academy of Sciences, Washington, DC
7. Human vitamin and mineral requirements. Water-soluble and fat-soluble vitamins. Calcium, magnesium, iodide, iron, selenium, zinc, antioxidants (2002), WHO and FAO, Rome
8. Allwood M.C., Martin H., Greenwood M., and Maunder M. Precipitation of trace elements in parenteral nutrition mixtures. Clin Nutr 17 (1998) 223-226
9. Hardy I.J., Martin H., and Hardy G. Selenium stability in vitamin and glutamine mixtures. Clin Nutr 24 (2005) 596
10. Ball P.A. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care 6 (2003) 319-325
11. Report of the Expert Group on Vitamins and Minerals. Statement on the mutagenicity of trivalent Chromium and Chromium picolinate. Com/04/S3-December 2004. Available at: http://www.advisorybodies.doh.gov.uk/com/chromium.htm. Accessed December 2008.
12. Moukarzel A.A., Song M.K., Buckman A.L., Vargas J., Gass W., and McDiarmid M. Excessive chromium intake in children receiving total parenteral nutrition. Lancet 339 (1992) 385-388
13. Tsuda K., Yokoyama Y., Morita M., Nakazawa Y., and Onishi S. Selenium and chromium deficiency during long term home parenteral nutrition in chronic idiopathic intestinal pseudo-obstruction. Nutrition 14 (1998) 291-295
14. Ding W.J., Chai Z.F., Duan P., Feng W., and Qian Q. Serum and urine chromium concentrations in elderly diabetics. Biol Trace Elem Res 63 (1998) 231-237
15. Jeejeebhoy K.N., Chu R.C., Marliss E., Greenberg G.R., and Bruce-Robertson A. Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation in a patient receiving long-term PN. Am J Clin Nutr 30 (1977) 531-538
16. Sudhakar M., and Kirby D.F. Micronutrient and trace element monitoring in adult nutrition support. Nutr Clin Pract 15 (2000) 120-126
17. Via M., Scurlock C., Raikhelkar J., Di Luozzo G., and Mechanick J.I. Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient. Nutr Clin Pract 23 (2008) 325-328
18. ASPEN Board of Directors and the Clinical Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN 26 suppl (2002) 23SA
19. Shenkin A. Trace elements and vitamins in parenteral and enteral nutrition. In: Sobotka L. (Ed). Basics in clinical nutrition. 3rd ed (2004), Galen, Prague, Czech Republic 169-175
20. Churchwell M.D., Pasko D.A., Btaiche I.F., Jain J.C., and Mueller B.A. Trace element removal during in vitro and in vivo continuous haemodialysis. Nephrol Dial Transplant 22 (2007) 2970-2977
21. Zappitelli M., Juarez M., Castillo L., Coss-Bu J., and Goldstein S.L. Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children. Intensive Care Med 35 (2009) 698-706
22. Mouser J.F., Hak E.B., Helms R.A., Christensen M.L., and Storm M.C. Chromium and zinc concentrations in pediatric patients receiving long-term parenteral nutrition. Am J Health Syst Pharm 56 (1999) 1950-1956
23. Hardy G., and Reilly C. Technical aspects of trace element supplementation. Curr Opin Clin Nutr Metab Care 2 (1999) 277-285
24. Ito Y., Alcock N.W., and Shils M.E. Chromium content of total parenteral nutrition solutions. JPEN 14 (1990) 610-614
25. Vincent J.B. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev 58 (2000) 67-72
26. Leung F.Y. Trace elements in parenteral micro-nutrition. Clin Biochem 28 (1995) 561-566
27. In: Austin P., and Stroud M. (Eds). Prescribing adult intravenous nutrition (2007), Pharmaceutical Press, London
28. Spiegel J., and Willenbucher R. Development of severe copper deficiency in a patient with Crohn's disease receiving parenteral nutrition. JPEN 23 (1999) 169-172
29. Forbes G.M., and Forbes A. micronutrient status in patients receiving home parenteral nutrition. Nutrition 13 (1997) 941-944
30. Shike M., Roulet M., Kurian R., Whitwell J., Stewart S., and Jeejeebhoy K.N. Copper metabolism and requirements in total parenteral nutrition. Gastroenterology 81 (1981) 290-297
31. Fujita M., Itakura T., Takagi Y., and Okada A. Copper deficiency during total parenteral nutrition: clinical analysis of three cases. JPEN 13 (1989) 421-425
32. Berger M.M., and Shenkin A. Trace elements in trauma and burns. Curr Opin Clin Nutr Metab Care 1 (1998) 513-517
33. Menéndez A.M., Montemerlo H., Weisstaub A., Alloatti S., Rusi F., Guidoni M.E., et al. Plasmatic and erythrocytic zinc and cooper levels in critically ill patients on parenteral nutrition and their relationship with formulas content: preliminary results. Nutr Hosp 20 (2005) 189-196
34. Menéndez A.M., Weisstaub A., Montemerlo H., Rusi F., Guidoni M.E., Piñeiro A., and Pita Martin de Portela M.L. Zinc and cooper content in individual components used to prepare pediatric total nutrition mixtures. Nutr Hosp 23 (2007) 545-551
35. Bergomi M., Rovesti S., Vinceti M., Vivoli R., Caselgrandi E., and Vivoli G. Zinc and copper status and blood pressure. J Trace Elem Med Biol 11 (1997) 166-199
36. Turnland J.R., and Copper. In: Shils M.E., Shike M., Ross A.C., Caballero B., and Cousins R.J. (Eds). Modern nutrition in health and disease. 10th ed (2005), Lippincott Williams & Wilkins, Philadelphia 286-299
37. National Kidney Foundation Dialysis Outcomes Quality Initiative. Clinical practice guidelines for the treatment of anemia of chronic renal failure: National Kidney Foundation Dialysis Outcomes Quality Initiative: 2000 update. Am J Kidney Dis 37 suppl 1 (2001) S186-S206
38. Muñoz M., Breymann C., García-Erce J.A., Gómez-Ramirez S., Comin J., and Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogenic blood transfusions. Vox Sang 94 (2008) 172-183
39. Hoen B., Kessler M., Hestin D., and Mayeux D. Risk factors for bacterial infections in chronic hemodialysis adult patients: a multicenter prospective survey. Nephrol Dial Transplant 10 (1995) 337-381
40. Weinberg E. Iron and infection. Microbiol Rev 42 (1978) 45-66
41. Tielemans C.L., Lenclud C.M., Wens R., Collart F.E., and Dratwa M. Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine. Nephrol Dial Transplant 4 (1989) 883-887
42. Swoboda S.M., and Lipsett P.A. Intravenous iron as a risk factor for bacteremia in the surgical intensive care unit patient. Surg Infect 6 (2005) 158
43. Corwin H.L., Gettinger A., Fabian T.C., May A., Pearl R.G., Heard S., An R., et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 357 (2007) 965-976
44. Napolitano L.M., Fabian T.C., Kelly K.M., Balley J.A., Block E.F., Langholff W., Enny C., et al. Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma 65 (2008) 2875-2897
45. Pieracci F.M., and Barie P.S. Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 34 (2006) 1898-1905
46. Lapointe M. Iron supplementation in the intensive care unit: when, how much, and by what route?. Crit Care 8 suppl 2 (2004) S37-S41
47. Kumpf V.J. Update on parenteral iron therapy. Nutr Clin Pract 18 (2003) 318-326
48. Danielson B.G. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol 15 (2004) S93-S98
49. WHO/UNICEF/ICCIDD. Iron deficiency anemia: assessment, prevention and control. WHO/NHD/013 (2001), World Health Organization, Geneva
50. Papet I., Meunier N., Béchereau F., Glomot F., Obled C., and Coudray C. Effect of zinc supplementation on protein metabolism in late-middle-aged men: the Zenith study. Nutrition 24 (2008) 155-161
51. Sazawal S., Black R.E., Jalla S., Mazumdar S., Sinha A., and Bhan M.K. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and pre-school children. Pediatrics 102 (1998) 1-5
52. Abu-Hamdan D.K., Migdal S.D., Whitehouse R., Rabbani P., Prasad A.S., and McDonald F.D. Renal handling of zinc: effect of cysteine infusion. Am J Physiol 241 (1981) F487-94
53. Cousins R., and Hempe J.M. Zinc. In: Brown M.L. (Ed). Present knowledge in nutrition. 6th ed (1990), Nutrition Foundation, Washington, DC 251-260
54. Braunschweig C.L., Sowers M., Kovacevich D.S., Hill G.M., and August D.A. Parenteral zinc supplementation in adult humans during the acute phase response increases the febrile response. J Nutr 127 (1997) 70-74
55. Berger M.M., Eggimann P., Heyland D.K., Chioléro R.L., Revelly J.P., Day A., et al. Reduction of nosocomial pneumonia after major burns by trace elements supplementation: aggregation of two randomised trials. Crit Care 10 (2006) R153
56. Agay D., Anderson R.A., Sandre C., Bryden N.A., Alonso A., Roussel A.M., and Chancerelle Y. Alterations of antioxidant trace elements (Zn, Se, Cu) and related metallo-enzymes in plasma and tissues following burn injuries in rats. Burns 31 (2005) 366-371
57. Berger M.M., and Shenkin A. Vitamins and trace elements: practical aspects of supplementation. Nutrition 22 (2006) 952-955
58. Berger M.M. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract 21 (2006) 438-449
59. Soguel L., Chioléro R.L., Ruffieux C., and Berger M.M. Monitoring the clinical introduction of a glutamine and antioxidant solution in critically ill trauma and burn patients. Nutrition 24 (2008) 1123-1132
60. Menéndez A.M., Montemerlo H., Weisstaub A., Alloatti S., Guidoni M.E., Rusi F., and Portela M.L. Relationship between the amount of cooper and zinc given to critically ill patients on total parenteral nutrition and plasma and erythrocyte cooper and zinc levels. Nutr Hosp 23 (2008) 373-382
61. Kohrle J., Brigelius-Flohe R., Bock A., Gärtner R., Meyer O., and Flohé L. Selenium in biology: facts and medical perspectives. Biol Chem 381 (2000) 849-864
62. Hardy G., and Hardy I. Selenium: the Se-XY nutraceutical. Nutrition 20 (2004) 590-593
63. Dodig S., and Cepelak I. The facts and controversy about selenium. Acta Pharm 54 (2004) 261-276
64. Rayman M.P. The importance of selenium to human health. Lancet 356 (2000) 233-241
65. Burk R.F., Hill K.E., and Selenoprotein P. an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 25 (2005) 215-235
66. Duffield A.J., Thomson C.D., Hill K.E., and Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 70 (1999) 896-903
67. Thomson C.D., Robinson M.F., Butler J.A., and Whanger P.D. Long term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase in blood components of New Zealand women. Br J Nutr 69 (1993) 577-588
68. Manzanares W., Biestro A., Galusso F., Torre M.H., Mañay N., Pittini G., et al. Serum selenium and glutathione preoxidase-3 activity: biomarkers of systemic inflammation in the critically ill. Intensive Care Med 35 (2009) 882-889
69. Manzanares Castro W. Selenium in critically ill patients with systemic inflammatory response syndrome. Nutr Hosp 22 (2007) 295-306
70. Angstwurm M.W.A., Engelmann L., Zimmermann T., Lehmann C., Spes C.H., and Abel P. Selenium in Intensive Care (SIC) study: results of a prospective, randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis and septic shock. Crit Care Med 35 (2007) 118-126
71. Maehira F., Miyagi I., and Eguchi Y. Selenium regulates transcription factor NF-kB activation during the acute phase reaction. Clin Chem Acta 334 (2003) 163-171
72. Jeong D.W., Yoo M.H., Kim T.S., Kim J.H., and Kim I.Y. Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-kappa B activation. J Biol Chem 277 (2002) 17871-17876
73. Stewart M.S., Spallholz J.E., Neldner K.H., and Pence B.C. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 26 (1999) 42-48
74. Chung Y.W., Kim T.S., Lee S.Y., Lee S.H., Chol Y., Kim N., et al. Selenite-induced apoptosis of osteoclasts mediated by the mitochondrial pathway. Toxicol Lett 160 (2006) 143-150
75. Forceville X., Laviolle B., Annane D., Vitoux D., Bleichner G., Korach J.M., et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care 11 (2007) R73
76. Vincent J.L., and Forceville X. Critically elucidating the role of selenium. Curr Opin Anesthesiol 21 (2008) 148-154
77. Heyland D.K. Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing?. Crit Care 11 (2007) 153
78. Manzanares W., Torre M.H., Biestro A., Galusso F., Mañay N., and Pitini G. Pharmacokinetics and pharmacodynamics of high dose selenium in systemic inflammatory response syndrome. Clin Nutr 3 suppl 1 (2008) 6-7
79. Gillanders L., Hardy I.J., and Hardy G. Is manganese an essential supplement for parenteral nutrition?. Curr Opin Clin Nutr Metab Care 11 (2008) 289-296
80. Reynolds N., Blumsohn A., Baxter J.P., Houston G., and Pennington C.R. Manganese requirement and toxicity in patients on HPN. Clin Nutr 17 (1998) 227-230
81. Fell J.M., Reynolds A.P., Meadows N., Khan K., Long S.G., Quaghebeur G., et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347 (1996) 1218-1221
82. Howard L., Ashley C., Lyon D., and Shenkin A. Autopsy tissue trace elements in 8 long-term parenteral nutrition patients who received the current US FDA formulation. JPEN 31 (2007) 388-396
83. Dickerson R.N. Manganese intoxication and parenteral nutrition. Nutrition 17 (2001) 689-693
84. Takagi Y., Okada A., Sando K., Wasa M., Yoshida H., and Hirabuki N. Evaluation of indexes of in vivo manganese status and the optimal intravenous dose for adult patients undergoing home parenteral nutrition. Am J Clin Nutr 75 (2002) 112-118
85. Ocaña M., and Hardy G. Trace element contamination of some HPN solutions. Nutrition 24 (2008) 508
86. Johnson J.L., Rajagopalan K.V., and Cohen H.J. Molecular basis of the biologic function of molybdenum. J Biol Chem 249 (1874) 859-866
87. Zhang Z., Naughton D., Winyard P.G., Benjamin N., Blake D.R., and Symons M.C. Generation of nitric oxide reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Comm 249 (1998) 767-772
88. Abrumad N.N., Schneider A.J., Steel D., and Rogers L.S. Amino acid intolerance during prolonged total parenteral nutrition reversed by molybdate therapy. Am J Clin Nutr 34 (1981) 2551-2559
89. Desthale Y.G., and Gopalan C. The effect of molybdenum levels in sorghum on uric acid and copper excretion in man. Br J Nutr 31 (1974) 351-355
90. Berner Y.N., Shuler E.R., and Nielsen F.H. Selected ultratrace elements in total parenteral nutrition solutions. Am J Clin Nutr 50 (1989) 1079-1083
91. ASPEN Board of Directors. Safe practices in parenteral nutrition. JPEN 28 suppl (2004) S39-S70